GASTRIC TOLERANCE OF SINGLE DOSE UNBUFFERED AND BUFFERED ACETYLSALICYLIC-ACID - A RANDOMIZED COMPARATIVE ENDOSCOPIC STUDY IN 24 VOLUNTEERS

被引:0
|
作者
ROGALLA, K [1 ]
LANGE, R [1 ]
PANIJEL, M [1 ]
机构
[1] INST INTERNAL MED, W-6000 FRANKFURT 1, GERMANY
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A randomized, three-way crossover study by gastroscopic examination in 24 healthy male volunteers was performed to compare the gastric tolerance of a single dose of buffered or unbuffered acetylsalicylic acid. Gastroscopic assessment was made two hours after administration of the buffered (800 mg ASA) or unbuffered (500 mg ASA) tablets taken with 200 ml of water. Mucosal changes were rare and of a minor nature. Only two volunteers in the unbuffered ASA group presented minor changes (erythema and oedema). No pathological changes were observed after the buffered ASA. Subjective adverse reactions, e.g. epigastric complaints, were reported by four volunteers in the unbuffered group and by two in the buffered group. Based on the limited number and the minor extent of visible changes, statistical tests did not appear to be warranted. The results indicate that buffered ASA is better tolerated.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 50 条
  • [31] A randomized, double blind, single dose, comparative study of the pharmacokinetics, safety and immunogenicity of MB02 (bevacizumab biosimilar) and reference bevacizumab in healthy male volunteers
    Sinn, Angela
    Garcia-Alvarado, Fernanda
    Gonzalez, Veronica
    Huerga, Camino
    Bullo, Felicitas
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (03) : 1063 - 1073
  • [32] Comparative Pharmacokinetic Study Among 3 Metformin Formulations in Healthy Mexican Volunteers: A Single-Dose, Randomized, Open-Label, 3-Period Crossover Study
    Lucia Montoya-Eguia, Sandra
    Garza-Ocanas, Lourdes
    Tadeo Badillo-Castaneda, Christian
    Tamez-de la O, Eduardo
    Zanatta-Calderon, Teresa
    Vinicio Gomez-Meza, Marco
    Garza-Ulloa, Humberto
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2015, 77 : 18 - 23
  • [33] COMPARATIVE BIOEQUIVALENCE EVALUATION OF TWO BRANDS OF OFLOXACIN 200 MG TABLETS (JEDCOFLACIN® VS. TARIVID®) IN 24 HEALTHY VOLUNTEERS: A RANDOMIZED, SINGLE-DOSE, TWO-PERIOD, TWO-SEQUENCE CROSSOVER STUDY
    Kadi, Adnan A.
    Al-Hadiya, Badraddin M.
    Attwa, Mohamed W.
    Abdelhameed, Ali S.
    El-Sayed, Yousry M.
    Attia, Mohamed Ibrahim
    DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2013, 8 (01) : 239 - 246
  • [34] Comparative bioavailability of two tablet formulations of emtricitabine/tenofovir in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study
    Keller, Guillermo A.
    Czerniuk, Paola
    Angel Bertuola, Roberto
    Mendez, Mariana
    Isabel Gimenez, Maria
    Di Girolamo, Guillermo
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (10) : 825 - 834
  • [35] COMPARATIVE BIOAVAILABILITY STUDY OF RHB-102 (ONDANSETRON 24 mg ER TABLETS QD) VERSUS ONDANSETRON 8 mg TABLETS BID AND A SINGLE DOSE OF ONDANSETRON 24 mg IN HEALTHY VOLUNTEERS.
    Sayegh, L.
    Paquette, J. M.
    Essalihi, R.
    Sicard, E.
    Noumeir, M.
    Massicotte, J.
    Lefebvre, M.
    Fathi, R.
    Plasse, T. F.
    Raday, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S47 - S48
  • [36] Comparative Bioavailability of 2 Tablet Formulations of Levodopa/Benserazide in Healthy, Fasting Volunteers: A Single-Dose, Randomized-Sequence, Open-Label Crossover Study
    Keller, Guillermo A.
    Czerniuk, Paola
    Bertuola, Roberto
    Spatz, Juan G.
    Assefi, Aria R.
    Di Girolamo, Guillermo
    CLINICAL THERAPEUTICS, 2011, 33 (04) : 500 - 510
  • [37] A COMPARATIVE, RANDOMIZED, SINGLE-DOSE, 2-WAY CROSSOVER BIOAVAILABILITY STUDY OF A CLONAZEPAM ORAL SOLUTION VS. TABLETS IN HEALTHY ADULT VOLUNTEERS.
    Marricco, N. Cardillo
    Bonhomme, M. C.
    Di Spirito, M.
    Offman, E. M.
    Cassidy, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S118 - S118
  • [38] Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers
    Kanjanawart, Sirimas
    Gaysonsiri, Dhanu
    Phunikom, Katcharin
    Simasathiansopon, Sontaya
    Tangsucharit, Panot
    Vannaprasaht, Suda
    Kaewkamson, Thanawat
    Tassaneeyakul, Wichittra
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (03) : 249 - 254
  • [39] A COMPARATIVE, RANDOMIZED, SINGLE-DOSE, 2-WAY CROSSOVER BIOAVAILABILITY STUDY OF A RAMIPRIL ORAL SOLUTION VS. TABLET IN HEALTHY ADULT VOLUNTEERS.
    Bonhomme, M. C.
    Marricco, N. Cardillo
    Di Spirito, M.
    Offman, E. M.
    Smith, S. P.
    Cassidy, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S122 - S122
  • [40] Pharmacodynamics and Pharmacokinetics of a Novel, Low-Dose, Soft-Gel Capsule of Acetylsalicylic Acid in Comparison with an Oral Solution After Single-Dose Administration to Healthy Volunteers: A Phase I, Two-Way Crossover Study
    Loprete, Luca
    Leuratti, Chiara
    Scarsi, Claudia
    Radicioni, Milko
    CLINICAL DRUG INVESTIGATION, 2014, 34 (01) : 19 - 25